Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial

Locoregional radiotherapy added to chemotherapy has significantly improved survival in de novo metastatic nasopharyngeal carcinoma (mNPC). However, only 54% of de novo mNPC patients who received sequential chemoradiotherapy have complete or partial response 3 months after radiotherapy. This Simon’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Si-Yuan, Duan, Xiao-Tong, Li, Hui-Feng, Peng, Lan, Wang, Zhi-Qiang, Xu, Gui-Qiong, Hua, Yi-Jun, Zou, Xiong, You, Rui, Ouyang, Yan-Feng, Liu, You-Ping, Gu, Chen-Mei, Yang, Qi, Jiang, Rou, Zhang, Meng-Xia, Lin, Mei, Xie, Yu-Long, Lin, Chao, Ding, Xi, Xie, Ruo-Qi, Duan, Chong-Yang, Zhang, Wei-Jing, Huang, Pei-Yu, Chen, Ming-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694661/
https://www.ncbi.nlm.nih.gov/pubmed/37951218
http://dx.doi.org/10.1016/j.xcrm.2023.101279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694661/
https://www.ncbi.nlm.nih.gov/pubmed/37951218
http://dx.doi.org/10.1016/j.xcrm.2023.101279

Ejemplares similares